Toxicity in intramammary dosed Holstein bovine assessed as increase in N-acetyl-beta-D-glucosamine in milk dosed after morning milking by irritancy test
Toxicity in Holstein bovine assessed as visible local reaction at 1.25X10'6 IU, intramammary dosed in left hindquarter of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as decreased milk yeild at 1.25X10'6 IU, intramammary dosed in left hindquarter of mammary gland of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as visible local reaction at 2.5X10'6 IU, intramammary dosed in right hindquarter of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as decreased milk yeild at 2.5X10'6 IU, intramammary dosed in right hindquarter of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as visible local reaction with swollen and tender mammary gland at 5X10'6 IU, intramammary dosed in right forequarter of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as decreased milk yeild with clots and flakes in milk at 5X10'6 IU, intramammary dosed in right forequarter of mammary gland after morning milking by irritancy test
Toxicity in Holstein bovine assessed as visible local reaction at 5X10'6 IU, intramammary dosed in right forequarter of mammary gland after morning milking after 24 hrs by irritancy test
Antiinflammatory activity in lactating Holstein bovine subclinical mastitis model assessed as reduction in number of mammary gland quarters with somatic cell count of >=5X10'5/ml at 2.5X10'6 IU, intramammary dosed after morning milking measured after 1 week
Antiinflammatory activity in lactating Holstein bovine subclinical mastitis model assessed as reduction in number of mammary gland quarters with somatic cell count of >=5X10'5/ml at 2.5X10'6 IU, intramammary dosed after morning milking measured after 2 weeks
Antiinflammatory activity in lactating Holstein bovine subclinical mastitis model assessed as reduction in N-acetyl-beta-D-glucosamine activity at 2.5X10'6 IU, intramammary dosed after morning milking measured after 1 week
Antiinflammatory activity in lactating Holstein bovine subclinical mastitis model assessed as reduction in N-acetyl-beta-D-glucosamine activity at 2.5X10'6 IU, intramammary dosed after morning milking measured after 2 weeks
Antibacterial activity against Staphylococcus aureus in lactating Holstein bovine subclinical mastitis model assessed as reduction in intramammary infections at 2.5X10'6 IU, intramammary dosed after morning milking relative to control
Antibacterial activity against Streptococcus agalactiae in lactating Holstein bovine subclinical mastitis model assessed as reduction in intramammary infections at 2.5X10'6 IU, intramammary dosed after morning milking relative to control